A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia...
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.
Griffith University researchers conducting a trial to prevent fractures from osteoporosis are looking for more participants after COVID-19 setbacks.
An Australian-first rehabilitation trial considered the next crucial step in treating paralysis will proceed after a record donation from the country’s leading spinal injury research foundation.
This is the fourth of a series of five blogs on COVID 19 and human rights, focusing on the timeline...
Clinical trial results find one-third of participants experienced immediate loss of pain and majority experienced significant improvements in their movement.
Researchers offer free trials to help reduce burden of osteoporotic fractures in older women.
